You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pertuzumab

Showing 51 - 75 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting
  • HER2+ Breast Cancer
  • Xi'an, Shaanxi, China
  • +1 more
Jun 20, 2022

Breast Cancer Trial in Budapest (Tamoxifen, Goserelin, Letrozole 2.5Mg Tab)

Not yet recruiting
  • Breast Cancer
  • Budapest, Hungary
    National Institute of Oncolgy
Nov 20, 2021

Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

Not yet recruiting
  • Breast Neoplasm
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022

HER2-positive Breast Cancer Trial in Iran, Islamic Republic of (Trastuzumab, Pertuzumab, Carboplatin)

Completed
  • HER2-positive Breast Cancer
  • Rasht, Guilan, Iran, Islamic Republic of
  • +43 more
Aug 31, 2021

Breast Cancer Trial in Nanjing (Pyrotinib, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Cancer
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Jun 2, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Breast Cancer, Breast Tumor, Breast Cancer Female Trial in Houston (Paclitaxel, Carboplatin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • +10 more
  • Houston, Texas
  • +1 more
May 15, 2022

Advanced HER2+Breast Cancer Trial in Worldwide (Alpelisib, Alpelisib matching Placebo, Trastuzumab)

Active, not recruiting
  • Advanced HER2+Breast Cancer
  • Fayetteville, Arkansas
  • +98 more
Dec 16, 2022

Breast Tumors Trial in United States (Trastuzumab, pertuzumab, lapatinib)

Completed
  • Breast Neoplasms
  • Birmingham, Alabama
  • +4 more
Sep 3, 2020

HER2-positive Breast Cancer Trial (Docetaxel, Carboplatin, Trastuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • (no location specified)
Jul 6, 2021

NSABP Biospecimen Discovery Project

Active, not recruiting
  • Breast Cancer
  • Gainesville, Florida
  • +4 more
Oct 4, 2021

Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Boston, Massachusetts
  • +12 more
Jan 10, 2023

Breast Cancer Trial in Shanghai, Tianjin (Trastuzumab, QL1209, Pertuzumab)

Unknown status
  • Breast Cancer
  • Shanghai, Shanghai, China
  • +1 more
Nov 10, 2020

Breast Cancer Trial in Qingdao (HS627, Pertuzumab)

Recruiting
  • Breast Cancer
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Aug 12, 2020

Locally Advanced Malignant Tumor, Breast Cancer Trial in New York (drug, other, procedure)

Completed
Has Results
  • Locally Advanced Malignant Neoplasm
  • Breast Cancer
  • New York, New York
    Columbia University Irving Medical Center
Aug 19, 2021

Early-stage Breast Cancer, HER2-positive Breast Cancer Trial in Sweden (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Early-stage Breast Cancer
  • HER2-positive Breast Cancer
  • Göteborg, Sweden
  • +7 more
Sep 22, 2021

HER2 Positive Breast Cancer Trial in Worldwide (Tucatinib, Trastuzumab, Pertuzumab)

Recruiting
  • HER2 Positive Breast Cancer
  • Phoenix, Arizona
  • +143 more
Jan 20, 2023

Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Germany (Ontruzant, Chemotherapy, Pertuzumab)

Recruiting
  • Breast Cancer
  • +3 more
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +10 more
Aug 30, 2021

Eribulin in the Treatment of Advanced Breast Cancer

Recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    Sun Yat Sen Memorial Hospital，Sun Yat sen University
Dec 19, 2020

Participants With Breast Cancer

Completed
  • Breast Cancer
  • Pertuzumab
  • Busan, Korea, Republic of
  • +36 more
Apr 30, 2021

Her2-Positive Breast Cancer Trial in New Haven (Pertuzumab, Trastuzumab, Paclitaxel)

Completed
Has Results
  • Her2-Positive Breast Cancer
  • Pertuzumab
  • +5 more
  • New Haven, Connecticut
    Yale University Smilow Cancer Hospital
Mar 18, 2020

Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Brasschaat, Belgium
  • +53 more
Nov 29, 2022

Breast Cancer Trial in Tampa, Philadelphia (HER-2 pulsed DC1, trastuzumab, pertuzumab)

Withdrawn
  • Breast Cancer
  • HER-2 pulsed DC1
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 7, 2021

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab, Pertuzumab, Paclitaxel)

Completed
  • Metastatic Breast Cancer
  • Amiens, France
  • +70 more
Mar 29, 2021